Key facts
- It has raised $3.1M; the latest was Seed Round ($3.1M) in Oct 2025.
- Notable investors include ShangBay Capital, Device of Tomorrow Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for PiezoLabs
- ·The full record, as it builds
Funding rounds
No funding rounds for PiezoLabs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PiezoLabs
Manufacturer of vascular devices intended to prevent or promote clot formation based on patient needs. The company specializes in potentially eliminating or reducing the need for dual antiplatelet therapy post-procedure, reducing bleeding and thrombotic risks, enabling clients to reduce the duration of dual antiplatelet therapy.
- Sector
- Healthcare
- HQ
- Lake Forest, CA, United States
- Founded
- 2023
- Website
- piezolabs.com/
- Ownership
- Privately Held (backing)
PiezoLabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PiezoLabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PiezoLabs in its N-PORT filings yet. We sweep new filings monthly.